MedicineWorld.Org
Your gateway to the world of medicine
Home
News
Cancer News
About Us
Cancer
Health Professionals
Patients and public
Contact Us
Disclaimer

Medicineworld.org: Detecting Breast Cancer Metastasis

Back to breast cancer blog Blogs list Cancer blog  


Subscribe To Breast Cancer Blog RSS Feed  RSS content feed What is RSS feed?

Detecting Breast Cancer Metastasis

Detecting Breast Cancer Metastasis
In the U.S., a novel technology soon may be available to detect the spread, or metastasis, of breast cancer earlier than now possible, as per research presented at the first international meeting on Molecular Diagnostics in Cancer Therapeutic Development, organized by the American Association for Cancer Research.

Since secondary tumors, ignited by spreading cancerous cells, and not the primary breast cancer tumor, are the primary cause of cancer death, early detection of metastatic spread is crucial to a woman's prognosis.

It should enable the patient's doctor to adjust the woman's therapy so that it will target the spreading cancer early, said Winfried H. Albert, Ph.D., chief scientific officer of AdnaGen, the German biotech company that developed the technology.

Albert said that the company's diagnostic tool, which is being reviewed in clinical studies at The University of Texas M. D. Anderson Cancer Center in Houston, can spot one cancerous cell in a typical blood sample. A typical sample is 5 milliliters and contains over 2.5 x 1010 cells.

As a biomarker for breast cancer metastasis, cancer cells circulating in the blood system have not been easy to detect and analyze because they are a "needle in the haystack" among the millions of cells in the bloodstream.

However, Albert said that AdnaGen's technology can detect the "needle" with a specificity of 97 percent (only three "false" positive results in tests of 100 seemingly healthy people).

"Metastasis commonly is detected by costly, cumbersome physical methods like computer tomography (CT)," added Albert. "We have seen cases, where our test was positive, when there was still no clinical evidence. But at a careful second look through a Computerized axial tomography scan, small metastatic lesions have been detected."

To produce its diagnostic tool, AdnaGen links an antibody-mix to magnetic beads. This antibody-mix is tailored to home in on specific molecular features, or antigens, of the respective cancer cells.

When exposed to a blood sample, the magnetic antibody-beads capture tumor cells possessing the specified antigens. A magnetic particle concentrator then removes the tumor cells labeled with the magnetic beads, and the cells are then analyzed to identify several gene products, including potential molecular targets for a specific drug.

Using this technology, AdnaGen discovered that the genetic signatures of the breast cancer and its metastases may differ, with the circulating tumor cells reflecting the gene expression profile of the metastases.

When a metastases has been diagnosed, therapys "commonly has been chosen as per the features of the primary tumor, neglecting the fact that metastases can differ considerably from them," Albert noted.

AdnaGen, which is marketing its breast cancer assay (as well as assays for colon and prostate cancer) in Europe, is awaiting the results of a clinical trial before applying for FDA approval to make the test available in the U.S.


Posted by: Janet    Source




Did you know?
In the U.S., a novel technology soon may be available to detect the spread, or metastasis, of breast cancer earlier than now possible, as per research presented at the first international meeting on Molecular Diagnostics in Cancer Therapeutic Development, organized by the American Association for Cancer Research.

Medicineworld.org: Detecting Breast Cancer Metastasis

BREAST CANCER MAIN| Home| Breast cancer news| Common terms| Breast cancer treatment| Breast cancer treatment by stage| Mammogram and breast cancer screening| Surgical treatment of breast cancer| Chemotherapy of breast cancer| Chemo drugs used in breast cancer| Doxorubicin| Cyclophosphamide| Methotrexate| Hormonal therapy of breast cancer| Radiation therapy of breast cancer| Monoclonal therapy| High dose chemotherapy for breast cancer| Recurrent breast cancer| Bisphosphonates and breast cancer| Pregnancy and breast cancer| Risk factors for breast cancer| Risk details| My risk| Comprehensive breast cancer information| Breast cancer statistics| African Americans and breast cancer| Ashkenazi and breast cancer| Asians| Hispanic| Men| Native Americans| Older women and breast cancer| Younger women| Pregnant women and breast cancer| BRCA|

Copyright statement
The contents of this web page are protected. Legal action may follow for reproduction of materials without permission.